Journal of Clinical Medicine (JCM) MDPI Revenue and Competitors
Estimated Revenue & Valuation
- Journal of Clinical Medicine (JCM) MDPI's estimated annual revenue is currently $9.9M per year.
- Journal of Clinical Medicine (JCM) MDPI's estimated revenue per employee is $140,000
Employee Data
- Journal of Clinical Medicine (JCM) MDPI has 71 Employees.
- Journal of Clinical Medicine (JCM) MDPI grew their employee count by 18% last year.
Journal of Clinical Medicine (JCM) MDPI's People
Name | Title | Email/Phone |
---|
Journal of Clinical Medicine (JCM) MDPI Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $10.6M | 76 | 6% | N/A | N/A |
#2 | $11.2M | 80 | 31% | N/A | N/A |
#3 | $35M | 74 | -3% | N/A | N/A |
#4 | $9.9M | 71 | 18% | N/A | N/A |
#5 | $35M | 70 | -5% | N/A | N/A |
What Is Journal of Clinical Medicine (JCM) MDPI?
Journal of Clinical Medicine is an international, peer-reviewed, open access journal of clinical medicine, published semimonthly online by MDPI.Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and many other databases.Journal Rank: JCR - Q2 (Medicine, General & Internal) / CiteScore - Q1 (General Medicine)Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 20.6 days after submission; acceptance to publication is undertaken in 2.5 days (median values for papers published in this journal in the first half of 2022).Impact Factor: 4.964 (2021) ; 5-Year Impact Factor: 5.098 (2021)
keywords:N/AN/A
Total Funding
71
Number of Employees
$9.9M
Revenue (est)
18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.2M | 73 | 35% | N/A |
#2 | $35M | 74 | -3% | N/A |
#3 | $10.6M | 76 | 6% | N/A |
#4 | $11.2M | 80 | 31% | N/A |
#5 | $11.5M | 82 | 28% | N/A |